An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient

Autor: Carlos, L.M., Burrows, F.S., Plit, M.L., Havryk, A.P., Benzimra, M., Pearson, R.F., Glanville, A.R., Darley, D.R., Thomson, C., Malouf, M.A.
Zdroj: In Journal of Heart and Lung Transplantation April 2020 39(4) Supplement:S95-S95
Databáze: ScienceDirect